Source link : https://www.newshealth.biz/health-news/fda-approves-first-prescription-app-for-depression/
The US Food and Drug Administration (FDA) has approved the first-ever prescription app for major depressive disorder (MDD). The app, Rejoyn, was developed by Otsuka Pharmaceutical and Click Therapeutics. It will be available by prescription only to adults aged 22 years or older, under the care of a clinician, who are already taking antidepressant medications. […]
Author : News Health
Publish date : 2024-04-05 20:43:47
Copyright for syndicated content belongs to the linked Source.
Categories